Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Carboplatin + Cetuximab in Recurrent/Metastatic SCCHN
NCT01283334Phase 2Completed
- Sponsor
- Emory University
- Start
- Jan 2011
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
Phase 2, open-label trial of everolimus in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Emory University. Started Jan 2011; status: completed.
02
Drugs
everolimus
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01283334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283334.